Connect Biopharmaceuticals' Series A Round

Connect Biopharmaceuticals raised a round of funding on January 24, 2017.

Connect Biopharmaceuticals is a clinical-stage company that discovers and develops novel immune modulators for the treatment of inflammation and cancer.…

Articles about Connect Biopharmaceuticals' Series A Round: